Correlation Between X4 Pharmaceuticals and Ionis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Ionis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Ionis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Ionis Pharmaceuticals, you can compare the effects of market volatilities on X4 Pharmaceuticals and Ionis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Ionis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Ionis Pharmaceuticals.
Diversification Opportunities for X4 Pharmaceuticals and Ionis Pharmaceuticals
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between XFOR and Ionis is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Ionis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ionis Pharmaceuticals and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Ionis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ionis Pharmaceuticals has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Ionis Pharmaceuticals go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and Ionis Pharmaceuticals
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 6.17 times more return on investment than Ionis Pharmaceuticals. However, X4 Pharmaceuticals is 6.17 times more volatile than Ionis Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. Ionis Pharmaceuticals is currently generating about -0.22 per unit of risk. If you would invest 50.00 in X4 Pharmaceuticals on August 27, 2024 and sell it today you would lose (16.00) from holding X4 Pharmaceuticals or give up 32.0% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
X4 Pharmaceuticals vs. Ionis Pharmaceuticals
Performance |
Timeline |
X4 Pharmaceuticals |
Ionis Pharmaceuticals |
X4 Pharmaceuticals and Ionis Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with X4 Pharmaceuticals and Ionis Pharmaceuticals
The main advantage of trading using opposite X4 Pharmaceuticals and Ionis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Ionis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ionis Pharmaceuticals will offset losses from the drop in Ionis Pharmaceuticals' long position.X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Ionis Pharmaceuticals vs. Arrowhead Pharmaceuticals | Ionis Pharmaceuticals vs. Biomarin Pharmaceutical | Ionis Pharmaceuticals vs. Incyte | Ionis Pharmaceuticals vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |